HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 193 filers reported holding HEALTH CATALYST INC in Q1 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,783,000 | -43.9% | 389,962 | -16.2% | 0.11% | -47.9% |
| Q2 2022 | $6,740,000 | -47.7% | 465,162 | -5.8% | 0.21% | -18.2% |
| Q1 2022 | $12,899,000 | -64.1% | 493,662 | -45.6% | 0.26% | -6.9% |
| Q4 2021 | $35,976,000 | +22.1% | 908,008 | +54.2% | 0.28% | -35.3% |
| Q3 2021 | $29,456,000 | -53.1% | 589,004 | -48.0% | 0.43% | +4.9% |
| Q2 2021 | $62,846,000 | +165.5% | 1,132,168 | +123.7% | 0.41% | +36.5% |
| Q1 2021 | $23,670,000 | +97.0% | 506,084 | +83.3% | 0.30% | +131.8% |
| Q4 2020 | $12,018,000 | +12.8% | 276,084 | -5.2% | 0.13% | -17.3% |
| Q3 2020 | $10,654,000 | +8.8% | 291,084 | -13.3% | 0.16% | -1.9% |
| Q2 2020 | $9,795,000 | +17.0% | 335,782 | +2.2% | 0.16% | -27.1% |
| Q1 2020 | $8,375,000 | -14.9% | 328,698 | +15.9% | 0.22% | +11.2% |
| Q4 2019 | $9,844,000 | +47.5% | 283,698 | +34.5% | 0.20% | +8.9% |
| Q3 2019 | $6,674,000 | – | 210,924 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Daventry Group, LP | 1,574,175 | $15,930,651 | 10.16% |
| First Light Asset Management, LLC | 2,930,144 | $29,653,057 | 2.82% |
| Nepsis Inc. | 905,804 | $9,166,736 | 2.81% |
| Granahan Investment Management | 1,177,903 | $11,920,378 | 0.42% |
| Rhenman & Partners Asset Management AB | 320,000 | $3,238,400 | 0.35% |
| Bares Capital Management | 700,000 | $7,084,000 | 0.30% |
| PIER 88 INVESTMENT PARTNERS LLC | 101,470 | $1,026,876 | 0.26% |
| Counterpoint Mutual Funds LLC | 24,086 | $243,750 | 0.20% |
| Brendel Financial Advisors LLC | 11,831 | $120 | 0.18% |
| CVS HEALTH Corp | 32,273 | $326,598 | 0.18% |